Search Results - Conor Knightly
- Showing 1 - 4 results of 4
-
1
-
2
Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults by Allison August, Christine A. Shaw, Heather Lee, Conor Knightly, Shiva Kalidindia, Laurence Chu, Brandon Essink, William Seger, Tal Zaks, Igor Smolenov, Lori Panther
Published 2022Artigo -
3
Safety and Immunogenicity of a Messenger RNA–Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial by Carlos Fierro, Daniel C. Brune, Marian Shaw, Howard Schwartz, Conor Knightly, Jiang Lin, Andrea Carfı́, Andrew Natenshon, Shiva Kalidindi, Caroline Reuter, Jacqueline M. Miller, Lori Panther
Published 2024Artigo -
4
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine by Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Karen L. Kotloff, Sharon E. Frey, Rick Novak, David Diemert, Stephen A. Spector, Nadine Rouphael, C. Buddy Creech, John McGettigan, Shishir Khetan, Nathan Segall, Joel Solis, Adam Brosz, Carlos Fierro, Howard Schwartz, Kathleen M. Neuzil, Lawrence Corey, Peter B. Gilbert, Holly Janes, Dean Follmann, Mary Marovich, John R. Mascola, Laura Polakowski, Julie E. Ledgerwood, Barney S. Graham, Hamilton Bennett, Rolando Pajón, Conor Knightly, Brett Leav, Weiping Deng, Haiyu Zhou, Shu Han, Melanie Ivarsson, Jacqueline M. Miller, Tal Zaks
Published 2020Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Virology
Biology
Gene
Immunology
Virus
Genetics
Immunogenicity
Messenger RNA
Respiratory system
Viral disease
Alternative medicine
Antibody
Antibody titer
Attenuated vaccine
Biochemistry
Clinical trial
Coronavirus disease 2019 (COVID-19)
Cytomegalovirus
Disease
Herpesviridae
Human Parainfluenza Virus
Human cytomegalovirus
Human metapneumovirus
Immune system
Infectious disease (medical specialty)
Nasal administration
Neutralization
Neutralizing antibody